Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: A pilot study

Human Reproduction

Volumn 28, Issue 5, 2013, Pages 1254-1260

  Polyzos, N P ^a   De Vos, M ^a   Corona, R ^a   Vloeberghs, V ^a   Ortega Hrepich, C ^a   Stoop, D ^a   Tournaye, H ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

Bologna criteria; corifollitropin alfa; highly purified HMG; IVF; poor ovarian response

Indexed keywords

CORIFOLLITROPIN ALFA; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; HUMAN; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVULATION; OVULATION INDUCTION; PILOT STUDY; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDY;

EID: 84876518395     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det045     Document Type: Article

References (16)

1. Ata B, Kaplan B, Danzer H, Glassner M, Opsahl M, Tan SL, Munne S. Array CGH analysis shows that aneuploidy is not related to the number of embryos generated. Reprod Biomed Online 2012;24: 614-620.
2. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril 2011; 95: 1031-1036.
3. De Vos A, Van de Velde H, Bocken G, Eylenbosch G, Franceus N, Meersdom G, Tistaert S, Vankelecom A, Tournaye H, Verheyen G. Does intracytoplasmic morphologically selected sperm injection improve embryo development? A randomized sibling-oocyte study. Hum Reprod 2013;28: 617-626.
4. Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2004;89: 2062-2070. (Pubitemid 38647174)
5. Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 2009;24: 3063-3072.
6. European Medicines Agency. EMEA/H/C/001106-IG/0117/G. 2011. http://www.ema.europa.eu/docs/en-GB/document-library/EPAR--Product-Information/ human/001106/WC500074786.pdf (30 November 2012, date last assessed).
7. Fatemi HM, Oberye J, Popovic-Todorovic B, Witjes H, Mannaerts B, Devroey P. Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. Fertil Steril 2010;94: 1922-1924.
8. Fauser BC, Mannaerts BM, Devroey P, Leader A, Boime I, Baird DT. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update 2009;15: 309-321.
9. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26: 1616-1624.
10. Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update 2012;18: 1-11.
11. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 2011;96: 1058-1061.e7.
12. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, Camus M, Devroey P, Tournaye H. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod 2012;27: 3481-3486.
13. Polyzos NP, Devos M, Humaidan P, Stoop D, Ortega-Hrepich C, Devroey P, Tournaye H. Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril 2013;99: 422-426.
14. Requena A, Landeras JL, Martinez-Navarro L, Calatayud C, Sanchez F, Maldonado V, Munoz M, Fernandez M, Gonzalez A, Lopez S et al. Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles? Hum Fertil (Camb) 2010;13: 41-49.
15. van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 2003; 79: 482-488. (Pubitemid 36293437)
16. Younis JS. The Bologna criteria for poor ovarian response; has the job been accomplished? Hum Reprod 2012;27: 1874-1875; author reply 5-6.